| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | BABH study: a double-blind, randomized national phase 3 study to evaluate efficacy and safety of bevacizumab for the treatment of severe bleedings in hemorrhagic hereditary telangiectasia (HHT) |
| Type de publication | Journal Article |
| Year of Publication | 2018 |
| Auteurs | Dupuis-Girod S., Saurin J., Philouze P., Decullier E., Riviore S., Cartier C., Altwegg R., Gilbert-Dussardier B., Hatron P.Y, Mohamed S., Duffau P., Corre R., Leguy-Seguin V, Chinet T., Lacombe P., Lesur G., Lesniak J., HarlO J.R, Carette M.F, Lavigne C., Laccourreye L., Oberti F., Grobost V, Magro P., Alric L., Pistorius M., S. Chehadeh E, Fargeton A., Pivot C., Paintaud G., Faure F. |
| Journal | ANGIOGENESIS |
| Volume | 21 |
| Pagination | 134 |
| Date Published | FEB |
| Type of Article | Meeting Abstract |
| ISSN | 0969-6970 |
